Skip to content
TREOCAPA

TREOCAPA

  • Home
  • About TREOCAPA
    • Aim of the study
    • Phase II
      • Study procedure
    • Phase III
      • Allocation of the participants in the study group
      • Study procedure
    • Potential risks & benefits
    • Participating centers
  • For public & patients
    • EFCNI: European Foundation for the Care of Newborn Infants
    • Patient information sheet – Phase II
    • Patient information sheet – Phase III
    • Factsheet designed by EFCNI
    • Q&A
  • For Investigators
  • Funding & sponsorship
  • News

For public & patients

This section of the website contains information specifically for patients, parents and other family members, as well as the broader public. There is detailed information about the European Foundation for the Care of Newborn Infants (EFCNI), some Frequently Asked Questions, as well as patient information leaflets for the phase 2 and phase 3 parts of the TREOCAPA trial.

Published April 11, 2022By Mélanie Durox
Categorized as Uncategorized

Post navigation

Previous post

About TREOCAPA

Next post

Aim of the study

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389.

The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

  • For public & patients
TREOCAPA
Proudly powered by WordPress.